Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare PONESIMOD (PONVORY) and SIPONIMOD (MAYZENT) — clinical data, side effects, and patient experiences.
PONVORY, Ponvory · S1P Receptor Modulator
How it works
12.1 Mechanism of Action Ponesimod is a S1P receptor 1 modulator that binds with high affinity to S1P receptor 1. Ponesimod blocks the capacity of lymphocytes to egress from lymph ...
Approved for
MAYZENT, Mayzent · S1P Receptor Modulator
How it works
12.1 Mechanism of Action Siponimod is an S1P receptor modulator. Siponimod binds with high affinity to S1P receptors 1 and 5. Siponimod blocks the capacity of lymphocytes to egress...
Approved for
Estimated frequency (%) based on clinical trial data
No head-to-head clinical studies found for PONESIMOD vs SIPONIMOD.
Both PONESIMOD and SIPONIMOD belong to the S1P Receptor Modulator class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.
Both medications are approved for to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, to include clinically isolated syndrome. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
PONESIMOD carries 4 FDA warnings. SIPONIMOD carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.